# ImmuneID, Inc. — Form D

ImmuneID, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-13. The offering totals $20.2M, of which $17.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-01-13
- Form: D
- Accession: 0001840105-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.2M
- Amount sold: $17.1M
- Remaining: $3.1M
- Investors: 11
- Date of first sale: 2020-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386228

## Issuer

- Name: ImmuneID, Inc.
- CIK: 0001840105
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 800 BOYLSTON STREET, BOSTON, MA, 02199
- Phone: 6176489100

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Lea Hachigian | Director | Boston, MA |
| Ittai Harel | Director | College Park, GA |
| Christoph Westphal | Director | CAMBRIDGE, MA |
| Lea Hachigian | Executive Officer | Boston, MA |
| Christoph Westphal | Executive Officer | CAMBRIDGE, MA |

## More

- [CIK 1840105 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1840105&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001840105-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.